High glucose attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.
This study was to investigate the effect of high glucose (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/STAT-3 signalling. Adult rat bone marrow multipotent progenitor cells (rMAPCs) were cultured to evaluate VEGF expression (both mRNA and protein) with or without exposure to HG for up to 48 hrs using RT-PCR and ELISA. JAK2 and STAT3 phosphorylation in rMAPCs was analysed by Western blotting. With cells in normal media, VEGF mRNA level after 24 hrs of culture was significantly increased by 15 times over baseline (day 0) with detectable level of VEGF protein intracellularly using immunofluorescence staining. Although there was no measurable VEGF in the media after 24 hrs of culture, a significant amount of VEGF was detected in the media after 48 hrs of incubation. VEGF expression was associated with constitutive activation of JAK2 and STAT3 in rMAPCs. However, VEGF mRNA level was significantly reduced without detectable VEGF in the media when rMAPCs exposed to HG for 48 hrs. Tyrosine-phosphorylation of JAK2 and STAT3 and nuclear translocation of phosphorylated STAT3 were significantly decreased in the cells exposed to HG for 48 hrs. When JAK2 and STAT3 phosphorylation was blocked by the selective inhibitor AG490, VEGF mRNA level was significantly decreased in rMAPCs in normal media by 80% with no detectable VEGF in the media. VEGF expression was significantly suppressed in rMAPCs cultured in HG media that was further reduced by AG490. VEGF expression in rMAPCs is impaired by HG possibly through inhibition of JAK2/STAT3 signalling.
Liu
Zehao
Z
Division of Cardiovascular Medicine, Davis Heart & Lung Research Institute, The Ohio State University Medical Center, Columbus, OH 43210, USA.
Lei
Minxiang
M
Jiang
Yuehua
Y
Hao
Hong
H
Chu
Ling
L
Xu
Jian
J
Luo
Min
M
Verfaillie
Catherine M
CM
Zweier
Jay L
JL
Liu
Zhenguo
Z
D000818:Animals; D017209:Apoptosis; D001973:Bromodeoxyuridine / Q000494:pharmacology; D049109:Cell Proliferation; D005786:Gene Expression Regulation; D005947:Glucose / Q000378:metabolism*; D053614:Janus Kinase 2 / Q000378:metabolism*; D008954:Models, Biological; D010766:Phosphorylation; D051381:Rats; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction; D013234:Stem Cells / Q000166:cytology*; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
D050796:STAT3 Transcription Factor; D042461:Vascular Endothelial Growth Factor A; C507927:Jak2 protein, rat; D053614:Janus Kinase 2; D001973:Bromodeoxyuridine; D005947:Glucose
Eur J Heart Fail. 2007 Aug;9(8):747-53
17481945
Am J Pathol. 2001 Sep;159(3):993-1008
11549592
Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1760-5
17545471
Nature. 1998 Jul 9;394(6689):145-51
9671298
Circulation. 1999 May 4;99(17):2239-42
10226087
Diabet Med. 2003 Feb;20(2):105-13
12581261
J Diabetes Complications. 2000 Nov-Dec;14(6):307-13
11120454
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2738-46
17525207
Am J Physiol Lung Cell Mol Physiol. 2007 Mar;292(3):L742-7
17122356
Rom J Intern Med. 2003;41(1):27-33
15529582
Exp Biol Med (Maywood). 2008 Jan;233(1):4-11
18156300
Diabetes Metab. 2001 Sep;27(4 Pt 1):436-47
11547217
Exp Eye Res. 2007 May;84(5):812-22
17331500
J Clin Invest. 2002 Feb;109(3):337-46
11827993
FASEB J. 2005 Aug;19(10):1296-8
15919761
J Biol Chem. 2000 Apr 7;275(14):10561-6
10744750
Oncogene. 2000 May 15;19(21):2548-56
10851053
Exp Hematol. 2006 Nov;34(11):1596-601
17046581
FASEB J. 2003 Aug;17(11):1562-4
12824281
J Tissue Eng Regen Med. 2007 Jan-Feb;1(1):51-9
18038392
Nature. 2002 Jul 4;418(6893):41-9
12077603
Am J Pathol. 1999 Feb;154(2):355-63
10027394
Am J Physiol Regul Integr Comp Physiol. 2006 Oct;291(4):R880-4
16728464
J Clin Invest. 2008 Feb;118(2):505-14
18172550
Diabetes Res Clin Pract. 2008 Jan;79(1):e1-4
17707541
J Cell Physiol. 2003 Nov;197(2):157-68
14502555
Folia Histochem Cytobiol. 2007;45(2):81-6
17597020
Oncogene. 2002 Mar 27;21(13):2000-8
11960372
Circulation. 2007 Nov 6;116(19):2119-26
17967769
Exp Hematol. 2002 Aug;30(8):896-904
12160841
Circulation. 2006 Jul 4;114(1 Suppl):I120-4
16820560
Circulation. 2002 Jan 22;105(3):373-9
11804995
Ann Thorac Surg. 2005 Jul;80(1):229-36; discussion 236-7
15975372
Curr Eye Res. 1995 Nov;14(11):1015-20
8585929
Nucleic Acids Res. 1995 Aug 25;23(16):3283-9
7667105
J Vasc Surg. 2005 Apr;41(4):699-707
15874936
Circulation. 2003 Sep 9;108 Suppl 1:II253-8
12970242
J Biol Chem. 2000 Oct 27;275(43):33189-92
10961983
Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):539-45
15653566
Am J Med. 2004 Mar 8;116 Suppl 5A:47S-63S
15019863
Diabetes Obes Metab. 2007 Nov;9(6):767-80
17924861
Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1744-51
15964918
FASEB J. 2006 Apr;20(6):661-9
16581974
Am J Hypertens. 2001 May;14(5 Pt 1):475-86
11368471
Circulation. 2007 Apr 10;115(14):1866-75
17389266
Int J Cardiol. 2007 Feb 7;115(2):220-8
16889848
Cell. 2006 Jan 13;124(1):175-89
16413490
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6231-5
8692797
J Mol Cell Cardiol. 2007 Jun;42(6):1009-15
17509611
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1749-53
10677529
Metabolism. 2004 May;53(5):550-5
15131756